Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.6937
-0.1133 (-14.04%)
At close: Jun 27, 2025, 4:00 PM
0.7400
+0.0463 (6.67%)
After-hours: Jun 27, 2025, 6:59 PM EDT
Nautilus Biotechnology Market Cap
Nautilus Biotechnology has a market cap or net worth of $87.51 million as of June 27, 2025. Its market cap has decreased by -73.34% in one year.
Market Cap
87.51M
Enterprise Value
-21.96M
1-Year Change
-73.34%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since March 26, 2021, Nautilus Biotechnology's market cap has decreased from $117.04M to $87.51M, a decrease of -25.23%. That is a compound annual growth rate of -6.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 101.80M | -51.74% |
| Dec 31, 2024 | 210.95M | -43.54% |
| Dec 29, 2023 | 373.66M | 66.44% |
| Dec 30, 2022 | 224.50M | -65.10% |
| Dec 31, 2021 | 643.18M | 449.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |